The 20 Best Usher Syndrome Doctors near Bronx, NY

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is rated as a Distinguished provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Sorsby Fundus Dystrophy, Leber Congenital Amaurosis, and Usher Syndrome.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Advanced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Saadia Rashid is an Ophthalmologist in Bronx, New York. Dr. Rashid is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration.

Umar Mian is an Ophthalmologist in Bronx, New York. Dr. Mian is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Diabetic Retinopathy, Retinopathy of Prematurity, Kallikrein Hypertension, Retinal Artery Occlusion, and Vitrectomy.

Yu Hyon Kim, MD, is an attending physician, Retina and Assistant Professor, Ophthalmology & Visual Sciences at Montefiore Einstein. His clinical focus is in all aspects of vitreoretinal diseases evaluation, treatment and surgery, with a special interest in retinovascular disease, diabetes, macular degeneration, sickle cell and vascular occlusions. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Diabetic Retinopathy, Retinal Artery Occlusion, Retinal Detachment, and Retinal Vein Occlusion.

Dr. Fisher is a clinical ophthalmologist specializing in vitreoretinal diseases. Dr. Fisher’s career is noteworthy in the areas of patient care, teaching, and research. He is the author of several textbooks in the field of vitreoretinal diseases and ultrasonography.AuthorDr. Fisher has published more than 50 scientific articles and numerous scientific exhibits and posters. He was a course director for the American Academy of Ophthalmology for over 22 years and a review editor for many prestigious ophthalmic journals. He has received numerous awards for national and international professorships and lectureships. He has also been awarded the coveted Senior Award from the American Academy of Ophthalmology.LecturesDr. Fisher has lectured throughout the United States and abroad in the areas of ultrasonography and vitreoretinal surgery, developing new techniques and instruments in his field as well as pioneering developments in ocular endoscopy. He was selected by departmental chairmen and section chiefs at major ophthalmology centers nationwide as one of the 400 best retina doctors in America.Developed InstrumentsDr. Fisher has developed numerous intraocular surgical instruments which have advanced the field of vitreoretinal surgery. These instruments include electromagnets as well as endoscopic techniques for situations where microscopic visualization is limited or impossible. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Late-Onset Retinal Degeneration, Adult-Onset Vitelliform Macular Dystrophy (AVMD), Age-Related Macular Degeneration (ARMD), Retinal Detachment, and Vitrectomy.

Elona Dhrami is an Ophthalmologist in Bronx, New York. Dr. Dhrami is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. Her top areas of expertise are Color Blindness, Kallikrein Hypertension, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Navid Hakimian is an Ophthalmologist in Bronx, New York. Dr. Hakimian is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Diabetic Retinopathy, Color Blindness, Ocular Toxoplasmosis, and Retinal Detachment.

Issac Moradi is an Ophthalmologist in Bronx, New York. Dr. Moradi is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Diabetic Retinopathy, Color Blindness, Kallikrein Hypertension, and Late-Onset Retinal Degeneration.

Jeremy Chess is an Ophthalmologist in Bronx, New York. Dr. Chess is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Color Blindness, Diabetic Retinopathy, Kallikrein Hypertension, and Late-Onset Retinal Degeneration.

Michael Pisacano is an Ophthalmologist in Bronx, New York. Dr. Pisacano is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Dry Eye Syndrome, Glaucoma, Kallikrein Hypertension, and Cataract.

Jonathan Sheindlin is an Ophthalmologist in Bronx, New York. Dr. Sheindlin is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Kallikrein Hypertension, Diabetic Retinopathy, Glaucoma, and Age-Related Macular Degeneration (ARMD).

Daniel Chechik is an Ophthalmologist in Bronx, New York. Dr. Chechik is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Central Serous Chorioretinopathy.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as an Advanced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

Ravi Radhakrishnan is an Ophthalmologist in Mount Vernon, New York. Dr. Radhakrishnan is rated as an Advanced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Usher Syndrome, Doyne Honeycomb Retinal Dystrophy, and Usher Syndrome Type 2A.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Advanced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Doyne Honeycomb Retinal Dystrophy, and Cone Dystrophy.

Damon Pettinelli is an Ophthalmologist in Bronx, New York. Dr. Pettinelli is rated as an Advanced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Pterygium, and Cataract.

Nathan Radcliffe is an Ophthalmologist in Bronx, New York. Dr. Radcliffe is rated as an Advanced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Cataract Removal.

Fiona Pathay is an Ophthalmologist in Bronx, New York. Dr. Pathay is rated as an Advanced provider by MediFind in the treatment of Usher Syndrome. Her top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Dry Eye Syndrome, and Cataract.

Dr. Jason Horowitz, Professor of Ophthalmology at Columbia University Irving Medical Center, joined Columbia in 2011 after a rewarding 25-year experience delivering retinal care to the Waterbury, Connecticut community. A graduate of Harvard College and Yale Medical School, Dr. Horowitz was an ophthalmology resident at Yale before completing a retinal fellowship at Cornell, where he trained under Dr. Stanley Chang.Dr. Horowitz’s interests in ophthalmology are wide ranging. He is currently Medical Director of the Residents’ Eye Clinic at Harkness, where some of the most complicated and diverse patients in the world are evaluated and treated for an astonishing variety of ocular diseases. In a completely different domain, Dr. Horowitz has assumed the role of performing essential evaluations for retinopathy of prematurity in the infant patients of the world famous neonatal intensive care unit at Columbia’s Morgan Stanley Children’s Hospital of New York.In yet another realm, Dr. Horowitz manages complex retinal and macular disorders in adults such as retinal detachments and macular pucker. Together with his 36 years of retinal practice experience, Dr. Horowitz employs the full range of cutting-edge medical and surgical modalities in his practice. He particularly values the ability to use the most improved, up-to-date laser, pharmacological, and surgical therapies to successfully prevent (and, in some cases, even correct) profound visual impairment in conditions such as diabetic retinopathy and macular holes or epiretinal membranes. Dr. Horowitz is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Retinopathy of Prematurity, Retinal Detachment, Glaucoma, Vitrectomy, and Iridectomy.